Bio-Pathological Factors of Prognostic Value in Colorectal Adenocarcinomas

M. Mottolese, S. Buglioli, G. Piperno, I. Sperduti, D. Giannarelli, C. D'Angelo, M. Cosimelli

Research output: Contribution to journalArticle

Abstract

About 40% of patients bearing a colorectal carcinoma will develop local or distant tumor recurrences. Integrated analyses of biopathological markers, predictive of tumor aggressiveness, may offer a more rational approach to adjuvant therapy planning. To this end we analyzed the correlation between p53 accumulation, bcl-2 expression with cell proliferation, DNA ploidy, and conventional histological parameters, by testing the prognostic significance of these variables in a series of 214 patients bearing a colorectal carcinoma. When these parameters were examined in the univariate analysis, significantly shorter disease free and overall survival were observed in patients bearing p53+ and bcl-2-tumors. In the multivariate analysis p53 accumulation and bcl-2 expression emerged as independent predictors respectively of worse and better clinical outcome also in Dukes' B stage identifying patients at higher risk to develop liver metastases. These results indicate that in colorectal adenocarcinomas a biological profile, based on the combined evaluation of p53 and bcl-2, can be useful in identifying high risk patients to be enrolled in an adjuvant setting mainly in early stage of the disease.

Original languageEnglish
Pages (from-to)163-166
Number of pages4
JournalJournal of Experimental and Clinical Cancer Research
Volume22
Issue number4 SUPPL.
Publication statusPublished - Dec 2003

Fingerprint

Adenocarcinoma
Colorectal Neoplasms
Ploidies
Tumor Biomarkers
Disease-Free Survival
Neoplasms
Multivariate Analysis
Cell Proliferation
Neoplasm Metastasis
Recurrence
Liver
DNA
Therapeutics

Keywords

  • Bio-marker
  • Colon cancer
  • Liver metastasis
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bio-Pathological Factors of Prognostic Value in Colorectal Adenocarcinomas. / Mottolese, M.; Buglioli, S.; Piperno, G.; Sperduti, I.; Giannarelli, D.; D'Angelo, C.; Cosimelli, M.

In: Journal of Experimental and Clinical Cancer Research, Vol. 22, No. 4 SUPPL., 12.2003, p. 163-166.

Research output: Contribution to journalArticle

@article{14cf6ab78b3d44c69e4060ec657c719c,
title = "Bio-Pathological Factors of Prognostic Value in Colorectal Adenocarcinomas",
abstract = "About 40{\%} of patients bearing a colorectal carcinoma will develop local or distant tumor recurrences. Integrated analyses of biopathological markers, predictive of tumor aggressiveness, may offer a more rational approach to adjuvant therapy planning. To this end we analyzed the correlation between p53 accumulation, bcl-2 expression with cell proliferation, DNA ploidy, and conventional histological parameters, by testing the prognostic significance of these variables in a series of 214 patients bearing a colorectal carcinoma. When these parameters were examined in the univariate analysis, significantly shorter disease free and overall survival were observed in patients bearing p53+ and bcl-2-tumors. In the multivariate analysis p53 accumulation and bcl-2 expression emerged as independent predictors respectively of worse and better clinical outcome also in Dukes' B stage identifying patients at higher risk to develop liver metastases. These results indicate that in colorectal adenocarcinomas a biological profile, based on the combined evaluation of p53 and bcl-2, can be useful in identifying high risk patients to be enrolled in an adjuvant setting mainly in early stage of the disease.",
keywords = "Bio-marker, Colon cancer, Liver metastasis, Prognosis",
author = "M. Mottolese and S. Buglioli and G. Piperno and I. Sperduti and D. Giannarelli and C. D'Angelo and M. Cosimelli",
year = "2003",
month = "12",
language = "English",
volume = "22",
pages = "163--166",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central Ltd.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Bio-Pathological Factors of Prognostic Value in Colorectal Adenocarcinomas

AU - Mottolese, M.

AU - Buglioli, S.

AU - Piperno, G.

AU - Sperduti, I.

AU - Giannarelli, D.

AU - D'Angelo, C.

AU - Cosimelli, M.

PY - 2003/12

Y1 - 2003/12

N2 - About 40% of patients bearing a colorectal carcinoma will develop local or distant tumor recurrences. Integrated analyses of biopathological markers, predictive of tumor aggressiveness, may offer a more rational approach to adjuvant therapy planning. To this end we analyzed the correlation between p53 accumulation, bcl-2 expression with cell proliferation, DNA ploidy, and conventional histological parameters, by testing the prognostic significance of these variables in a series of 214 patients bearing a colorectal carcinoma. When these parameters were examined in the univariate analysis, significantly shorter disease free and overall survival were observed in patients bearing p53+ and bcl-2-tumors. In the multivariate analysis p53 accumulation and bcl-2 expression emerged as independent predictors respectively of worse and better clinical outcome also in Dukes' B stage identifying patients at higher risk to develop liver metastases. These results indicate that in colorectal adenocarcinomas a biological profile, based on the combined evaluation of p53 and bcl-2, can be useful in identifying high risk patients to be enrolled in an adjuvant setting mainly in early stage of the disease.

AB - About 40% of patients bearing a colorectal carcinoma will develop local or distant tumor recurrences. Integrated analyses of biopathological markers, predictive of tumor aggressiveness, may offer a more rational approach to adjuvant therapy planning. To this end we analyzed the correlation between p53 accumulation, bcl-2 expression with cell proliferation, DNA ploidy, and conventional histological parameters, by testing the prognostic significance of these variables in a series of 214 patients bearing a colorectal carcinoma. When these parameters were examined in the univariate analysis, significantly shorter disease free and overall survival were observed in patients bearing p53+ and bcl-2-tumors. In the multivariate analysis p53 accumulation and bcl-2 expression emerged as independent predictors respectively of worse and better clinical outcome also in Dukes' B stage identifying patients at higher risk to develop liver metastases. These results indicate that in colorectal adenocarcinomas a biological profile, based on the combined evaluation of p53 and bcl-2, can be useful in identifying high risk patients to be enrolled in an adjuvant setting mainly in early stage of the disease.

KW - Bio-marker

KW - Colon cancer

KW - Liver metastasis

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=1842583240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842583240&partnerID=8YFLogxK

M3 - Article

C2 - 16767924

AN - SCOPUS:1842583240

VL - 22

SP - 163

EP - 166

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 4 SUPPL.

ER -